Exosome Extraction
Made Simple.

Our mission is to democratize exosome enrichment by providing powerful, easy-to-use tools for exosome isolation and analysis.

Feature imageFeature imageFeature imageFeature imageFeature image

LabSpinner: Revolution in a Spin

Stop wasting precious samples.  
Start discovering breakthroughs. 

LabSpinner, an lab instrument brand of ExoDiscovery Technologies Inc., is transforming laboratory sample processing with microfluidic platforms that work smarter, not harder.
Lab-on-a-Disc Technology That Actually Works
‍Forget pumps and complicated plumbing. Our patented ExoDisc lab-on-a-disc platform harnesses centrifugal force to move fluids with precision—automating mission-critical procedures on a compact benchtop system that delivers results you can trust.
Why Our Customers Choose LabSpinner:
✓ Maximize Every Drop: minimize sample waste when every specimen counts
✓ Consistent, reproducible results: eliminate variability across runs
✓ Hands-Free Automation: Spend less time processing, more time discovering
✓ Clinical-Grade Precision: High-yield, high-purity isolation every time
Leading the Change in Extracellular Vesicle Research
Our ExoDisc cartridges are purpose-built for breakthrough biomarker discovery and precision medicine. Extract high-quality extracellular vescicles and exosomes from plasma, urine, cell culture supernatants, and other biological fluids, with unmatched purity and yield.
One Platform. Unlimited Possibilities.
From academic labs to clinical diagnostics, LabSpinner empowers researchers to perform sophisticated sample prep protocols with minimal hands-on time and maximum confidence.
LabSpinner - Where Exosome Innovation Meets Reliability

Our Leadership Team

Kyu Lee, Ph.D.
Co-Founder & Chief Executive Officer
Serial biotech entrepreneur who co-founded Clinomics ($200M+ IPO) and served as its CTO before founding ExoDiscovery. Previously worked at Samsung Advanced Institute of Technology as a genomics and bioinformatics expert. PhD in Materials Science and Engineering from University of Illinois at Urbana-Champaign with expertise in in vitro diagnostics, genetic analysis, and microfluidics technologies.
linkedin logo
Yoon Cho, Ph.D.
Co-Founder & Chief Scientific Officer
Pioneering researcher in liquid biopsy and professor in Biomedical Engineering at UNIST. Fellow of the Royal Society of Chemistry and recipient of the Presidential Medal for Scientific Excellence. PhD in Materials Science and Engineering from University of Illinois at Urbana-Champaign with over 10 years at Samsung Advanced Institute of Technology. Full member of the National Academy of Engineering of Korea.
linkedin logo
David Lee, Ph.D.
Chief Technology Officer
Expert in developing and commercializing in vitro diagnostics who led Lab-on-a-Chip projects at Samsung Electronics, including FDA approval processes. Previously worked at Samsung Advanced Institute of Technology developing Samsung IVD products. PhD in Chemical Engineering from POSTECH with recognition from both the Samsung Group and Korean National Industrial Technology Association for excellence in innovation.
linkedin logo
Minchan Kim
Chief Operating Officer
Minchan drives operational growth at ExoDiscovery, combining healthcare and business expertise. Previously, he managed over $2 billion in private equity and debt transactions at CVC Capital Partners and IDF Debt Fund in New York. He specializes in scaling complex healthcare organizations and optimizing operations across technology-enabled services, digital infrastructure, and logistics. At ExoDiscovery, Minchan oversees laboratory expansion, business development, and financial strategy.
linkedin logo